Inogen
INGN
155 hedge funds and large institutions have $1.1B invested in Inogen in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 56 increasing their positions, 51 reducing their positions, and 22 closing their positions.
17% more capital invested
Capital invested by funds: $935M → $1.1B (+$160M)
10% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 51
1.27% less ownership
Funds ownership: 94.63% → 93.36% (-1.3%)
4% less funds holding
Funds holding: 161 → 155 (-6)
18% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 22
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
52% less call options, than puts
Call options by funds: $950K | Put options by funds: $2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.6M |
| 3 |
BAMCO Inc
New York
|
+$12.1M |
| 4 |
BlackRock
New York
|
+$6.76M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$5.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$39.4M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$6.63M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.53M |
| 4 |
Goldman Sachs
New York
|
-$5.08M |
| 5 |
Renaissance Technologies
New York
|
-$4.28M |
INGN Hedge Fund Activity: Q1 2021 in Review
155 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q1 2021, worth a combined $1.1B — up 17% from $935M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of INGN and 18 opened new positions — a net loss of 4 holders — while 51 trimmed existing stakes and 56 added.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $15.8M. The largest seller was Novo Holdings A/S, cutting an estimated $39.4M.
- 155 institutional investors held Inogen (INGN) as of Q1 2021, down from 161 in Q4 2020.
- Funds reported $1.1B of Inogen stock for Q1 2021, up 17% quarter-over-quarter.
- 18 funds opened new Inogen positions in Q1 2021 and 22 closed out, a net change of -4 holders.
- The largest Inogen buyer in Q1 2021 was Fidelity Investments, an estimated $15.8M added.
- The largest Inogen seller in Q1 2021 was Novo Holdings A/S, an estimated $39.4M sold.
Based on aggregated 13F filings for Q1 2021.